Merck KGaA: Between AI Chips and Blockbuster Therapies – Bio-Techne Acquisition Aims to Secure Growth

Stocks in the healthcare sector can attract the attention of investors in the currently volatile market phase. In this context, I find the Merck KGaA particularly interesting. The company is especially exciting because it has three independent business divisions. The areas of Life Science, Healthcare, and Electronics each address different potential growth drivers. For example, they supply essential materials for the semiconductor industry. Recently, the Life Science segment was in focus as they announced on June 25 the agreement to acquire Bio-Techne...